A targeted, low-throughput compound screen in a Drosophila model of Neurofibromatosis Type 1 identifies simvastatin and BMS-204352 as potential therapies for autism spectrum disorder (ASD). https://www.biorxiv.org/content/10.1101/2022.11.11.516139?med=mas